Host human leukocyte antigens (HLAs) integrated into the human immunodeficiency virus (HIV) type 1 envelope could theoretically determine, as in tissue transplants, whether HIV-1 is "rejected" by exposed susceptible persons, preventing transmission. HLA discordance (mismatch) was examined among 45 heterosexual partner pairs in which at least 1 partner was HIV-1 infected and exposure or transmission between partners had occurred. Immunologic discordance at class II HLA-DRB3 (present in the HIV donor partner but absent in the recipient partner) was associated with lack of transmission of HIV-1. Eight (35%) of 23 partner pairs in which HIV-1 transmission did not occur were immunologically discordant at HLA-DRB3, compared with 0 of 11 partner pairs in which HIV-1 transmission did occur (P ¼ :027). Further investigation of the roles of class II HLAs in HIV-1 transmission and as possible components of HIV-1 vaccines should be pursued.
Despite repeated exposures, transmission of human immunodeficiency virus (HIV) type 1 between sex partners does not always occur. HLAs may be one immunologic factor affecting transmission. Class I HLAs are present on most somatic cells; class II HLAs are present on B cells, activated T cells, macrophages, dendritic cells, and thymic epithelial cells [1] . Class I HLAs have been of particular interest in relation to HIV-1 transmission because they direct cytotoxic T lymphocyte (CTL) response [2] , and anti-HIV-1 CTL activity is detectable in some persons who are exposed to HIV-1 repeatedly but who remain uninfected [3] . Although macaques immunized with class I HLA proteins develop humoral responses, they are not protected from subsequent infection with simian immunodeficiency virus (SIV) [4] .
Class II HLAs may also be important in protection from HIV-1 transmission. For example, macaques immunized with class II HLA-DR proteins are refractory to infection with SIV grown in human cells [4] . Examination of the HIV-1 envelope reveals that class II HLA-DR antigens are incorporated into the HIV-1 membrane [5, 6] and are the most abundant host molecule bound to the virus [7] . In fact, the HIV-1 envelope appears to contain much more DR antigen than does an equivalent amount of human cell membrane (T.W.H., unpublished data), suggesting that there may be a viral mechanism for sequestering or up-regulating the expression of DR antigen.
Given this "marking" of the virus with host HLA, one may conceptualize transmission of HIV-1 between persons as a form of "tissue transplant," with an HIV-infected partner acting as an HIV donor. As such, successful transmission (transplant) may rely not only on characteristics of the virus and the recipient but also on characteristics (such as HLA matching) of the donorrecipient pair. It would then be theoretically possible that HLA mismatching (discordance) between partners may result in "rejection" of HIV-1 and failure of transmission.
Investigation of the contribution of donor-recipient factors to HIV-1 transmission has been limited largely by the epidemiology of transmission. It is difficult to identify HIV-concordant partners between whom HIV-1 transmission has definitely occurred and appropriate HIV-discordant partners for comparison between whom substantial HIV-1 exposure has occurred. The Informed consent from all Mississippi participants for future research use of blood samples and institutional review board (IRB) approval for HLA testing was obtained; informed consent from all California participants and IRB approval for HLA testing was obtained. Human experimentation guidelines of the US Department of Health and Human Services were followed. present analysis uses samples from 2 epidemiologic studies in which such HIV-concordant and HIV-discordant partner pairs were identified, to assess the relationship between HLA discordance (mismatch) within heterosexual couples and protection from HIV-1 transmission.
Methods
Epidemiologic analyses and identification of appropriate partner pairs. Partner pairs in which at least 1 partner was HIV infected and exposure or transmission had occurred with reasonable certainty were identified from 2 epidemiologic studies: an investigation of a cluster of HIV-infected persons in rural Mississippi [8] and the California Partners Study II, an intervention trial for HIV-discordant couples in California [9] .
In the 1999 Mississippi investigation, all recent sex partners of HIV-infected persons were identified and notified, 78 persons were tested for HIV, and a cluster of HIV-infected persons and their uninfected partners was diagrammed [8] . To determine mode and relatedness of HIV-1 transmission, histories were taken regarding timing and frequency of sexual relations and the presence of nonsexual risk factors for HIV-1, and network analysis was performed. Partner pairs in which the uninfected partner reported using condoms all or most of the time and those who had not had sexual relations during the past 2 years were excluded from this analysis. The number of sex acts per couple was calculated from reports of the duration of the sexual relationship and the number of (vaginal or anal) sex acts per week. This information was not available for 3 pairs. Condom use was reported separately. Because all pairs reporting condom use "always" or "almost always" were excluded from the analysis, the number of reported sex acts represents mostly unprotected sex, but may include instances of protected sex.
The California Partners Study II began recruiting heterosexual partner pairs in December 1996. Partner pairs in which the male partner was HIV infected and the female partner was HIV uninfected but reported at least 5 episodes of unprotected sexual intercourse with the infected partner during the prior 2 years were enrolled into a biologic substudy. Pairs in which both partners were HIV infected were enrolled as controls. Only those HIV-concordant pairs in which the male partner had risks for HIV-1 outside the pair (malemale sex, injection drug use, blood transfusion, or sex with a person known to be HIV infected) but the female partner did not were included in this analysis. The number of unprotected vaginal sex acts was calculated from the reported number of vaginal sex acts per month, subtracting the frequency of condom use per month.
Laboratory testing. Archived peripheral blood mononuclear cell samples from the identified partner pairs were obtained and used for HLA testing. Class I typing was performed for HLA-A, -B, and -C; class II typing was performed for HLA-DRB1, -DRB3, -DRB4, -DRB5, and -DQB1.
Mississippi cell samples (control-rate frozen and stored at 2130 C) were tested at the Emory University Hospital HLA laboratory (Atlanta) by use of commercial kits (One Lambda: class I, low-resolution typing kit SSP1L lot 002; class II, high-resolution typing kit SSP2H lot 002).
California cell samples (frozen at 280 C overnight and stored at vapor phase liquid nitrogen) were tested at Immunologic Associates of Denver by the Lifecodes sequence-specific oligonucleotides probe system. The relevant sequences within the class I and class II regions were amplified using appropriate primers and polymerase chain reaction. Each amplified product was blotted onto several replicate membranes, one membrane for each probe. Then several individual membranes were probed, and hybridization was detected by chemiluminescence.
Analysis of HLA types. HLA-A, -B, -C, -DRB1, and -DQB1 were analyzed at the family (2-digit) level. Discordance was defined as no alleles in common between partners at a given locus (table 1  and table 2) . HLA-DRB3, -DRB4, and -DRB5 are linked to the DRB1 locus and may be "present" or "absent," as determined by the DRB1 type. Analysis of immunologic discordance at these loci depends on directionality of transmission. Immunologic discordance was defined, as in tissue transplants, as the presence of at least 1 allele in the HIV donor partner and the complete absence in the HIV recipient partner (table 1 and table 2) , because this discordance would theoretically be expected to provoke an immune response by the recipient. Family level analysis of these sites was not performed because the importance of the minimal polymorphisms at these sites has not been clearly established. Statistical analysis was performed by use of x 2 analysis, with 1-tailed Fisher's exact P values reported to assess the likelihood that discordance decreased risk of infection.
Results
Epidemiologic analyses and identification of appropriate partner pairs. From the Mississippi investigation, 6 HIV-concordant and 6 HIV-discordant partner pairs were included in the analysis. Specifically, 2 HIV-infected men and their 5 HIV-infected and 10 HIV-uninfected female partners were identified. These persons formed 6 HIV-concordant and 11 HIV-discordant heterosexual partner pairs (some persons were members of . 1 partner pair). Five HIV-discordant partner pairs were eliminated from the analysis, 3 because the HIV-uninfected partner reported condom use all or most of the time and 2 because they reported no sexual relations in the prior 2 years. All subjects were black. Sex histories, risk factor histories, and network analysis supported the premise that HIV-1 infection had occurred via heterosexual transmission within the cluster; no other exposures were identified [8] . Substantial HIV-1 exposure had likely occurred between partners: the number of sex acts (vaginal or anal intercourse) over 2 years was higher for the HIV-discordant, compared with the HIV-concordant, partner pairs (median, 156 and 88 sex acts, respectively), although the difference was not statistically significant (P ¼ :54, Wilcoxon rank sum test).
From the California study, 7 HIV-concordant and 26 HIVdiscordant partner pairs were included in the analysis. Specifically, we identified 19 HIV-concordant partner pairs and eliminated 12 for whom the female partner had other potential exposures to HIV-1 (injection drug use or sexual intercourse with a high-risk or HIV-infected person outside the partner pair). Although we identified 28 HIV-discordant partner pairs, insufficient cell samples were available for 2 partner pairs. The race or ethnicity of persons included in the analysis was as follows: black, 42%; non-Hispan-ic white, 38%; other/not characterized, 8%; Native American, 6%; Hispanic, 5%; and Asian, 1%. Substantial HIV-1 exposure had likely occurred between partners: the number of unprotected vaginal sex acts over 2 years was similar for the HIV-discordant and HIV-concordant partner pairs (median, 120 and 144 sex acts, respectively; P ¼ :17, Wilcoxon rank sum test).
HLA analysis. HLA types for couples from the Mississippi investigation and from the California study are shown in table 1  and table 2 , respectively, with summary results in table 3. Among the Mississippi partner pairs, 4 (67%) of 6 HIV-discordant partner pairs were immunologically discordant at class II HLA-DRB3 (present in the HIV-positive donor partner but absent in the recipient partner), compared with 0 of 6 HIV-concordant partner pairs (P ¼ :03). Among the California partner pairs, 4 (15%) of 26 HIV-discordant partner pairs were immunologically discordant at HLA-DRB3, compared with 0 of 7 HIV-concordant partner pairs (P ¼ :37). Overall, in a combined analysis limited to those partner pairs in which HLA-DRB3 was present in the HIV donor partner-and, thus, there was the possibility that the donor's HLA provoked an immune response in a recipient-0 of 11 HIV-concordant partner pairs but 8 (35%) of 23 HIV-discordant partner pairs were discordant at HLA-DRB3 (P ¼ :027).
Although not statistically significant, the median number of sex acts over 2 years was highest among the partner pairs who were immunologically discordant at HLA-DRB3, indicating that no HIV-1 transmission had occurred despite substantial HIV-1 exposure between partners. For the HLA-DRB3-discordant Mississippi pairs, the median number of sex acts was 208, compared with 88 for the HIV-concordant pairs ( P ¼ :24, Wilcoxon rank sum test). For the HLA-DRB3-discordant California pairs, the median number of unprotected sex acts was 382, compared with 144 for the HIV-concordant pairs (P ¼ :13, Wilcoxon rank sum test).
Differences in concordance at other HLA loci (table 3) or in total number of concordant class I and/or class II alleles were not associated with transmission of HIV between partners. Although the direction of HIV-1 transmission was not certain for some of the Mississippi partner pairs, this uncertainty affected interpretation of only 1 pair of alleles (table 1) and did not affect the results of the analysis.
Discussion
The present study is one of the first to examine the relationship between class I and class II HLA discordance and HIV-1 transmission within heterosexual partner pairs and the first to find an association between discordance at class II HLA-DRB3 and protection from HIV-1 infection. Couple-level analysis of HLA discordance is uncommon [10] [11] [12] , largely because of the difficulty in identifying appropriate partner pairs. One study found a higher degree of HLA concordance among couples who transmitted HIV-1, compared with those who did not transmit, but concordance at HLA-DRB3 was not specifically analyzed [10] . Concordance at class I HLAs [13] and class II HLA-DQ (M. Bulterys, unpublished data) have been associated with increased perinatal HIV-1 transmission, but, because the immunologic relationship between parent and child is unique and necessarily haplo-identical, these results may not translate directly to sex partners.
Other studies of HLA type and sexual HIV-1 transmission have focused on the frequency of alleles among HIV-infected persons, compared with HIV-uninfected (but exposed) persons or with population norms, and have described inconsistent associations with a variety of HLA alleles [11, [14] [15] [16] . Such variability may be expected if HLA types affect transmission in a relative (in response to donor HLAs), rather than absolute, way.
The clinical transplant level approach taken in this analysis is uncommon. HLA studies often adopt detailed molecular level analysis because of relationships between discrete genetic polymorphisms and altered immune response [17] . In such analyses, DRB3 alleles may be included in haplotype descriptions but are not often analyzed independently because they are not highly polymorphic and have been considered minor antigens. DRB3 is linked to DRB1, and linkage disequilibrium with DRB1 could contribute to findings associated with DRB3. However, characterization of HLA-DRB3 at the general level of "present" or "absent" is routinely used clinically in tissue transplants. DRB3 itself may be highly immunogenic in transplants with HIV concordant (n = 11) 0 HIV discordant (n = 23) 35 P .027
NOTE. Data are the percentage of couples discordant at each locus, except where noted. No statistically significant differences in HLA discordance were observed among California couples. Given the similarity of results of discordance at HLA-DRB3 in the California and Mississippi couples, with no HIV transmission between DRB3-discordant partners, a combined analysis was performed (see text).
a Combined DRB3 analysis includes only couples in which DRB3 was present in the HIV donor partner. b The denominator changes because of missing data (i.e., the no. of people with alleles available for analysis changes). antibodies produced against the DRB3 gene product (DR52) in donor-recipient mismatch (immunologic discordance) at DRB3 [18] . The statistical significance of the association between DRB3 discordance and protection from HIV-1 infection reaches significance in the combined analysis. Of note, no HIV-1 transmission occurred between partners who were immunologically discordant at DRB3, despite a higher frequency of unprotected sex acts. Although some persons in the Mississippi cluster are in .1 couple, the unit of analysis is not the individual but the partner pair, and HLA mismatching for a particular partner pair should not affect HLA mismatching for other pairs. In addition, because sexual relationships in the Mississippi cluster were mostly concurrent over the same 2-year period, many factors that could impact transmission (host characteristics, virus characteristics, and host immunologic/virologic status over time) are held relatively constant, allowing for better isolation of the contribution of HLAs to transmission.
There are several unavoidable limitations to this study. First, the sample size is necessarily small, limited by the ability to identify partners between whom HIV-1 transmission had occurred. Second, the analysis of multiple factors within small samples may find an association through random error alone. However, the degree and direction of the association between DRB3 discordance and protection from HIV-1 transmission were found independently in the Mississippi and California samples. Repetition of this analysis in additional partner pairs is necessary. Third, the high frequency of DRB3 presence (79%) among the female partners in the California cohort limited the magnitude of detectable effect, because DRB3 immunologic discordance was observed in only 12% of all partner pairs. Population frequencies of DRB3 presence vary by race and region. For example, DRB3 is present in 30%-40% of white Americans but in 45%-64% of black Americans [19] . Accordingly, the overall contribution of DRB3 discordance to protection from HIV-1 transmission may vary by population; modeling the potential contribution of DRB3 discordance among populations with high, compared with low, HIV-1 prevalence may be useful. Finally, the precise timing of HIV-1 transmission between most partners in this study was not known, so the potential contributions of other biologic factors, such as CD4 T lymphocyte count, HIV-1 RNA level, and sexually transmitted infections at the time of transmission, could not be assessed. Studies of incident HIV-1 infections may help assess the relative contribution of such time-variable biologic factors to transmission.
Given the important role of DRB3 matching in tissue transplants, the presence of class II DR antigens in the HIV-1 envelope [5] [6] [7] and the successful immunization of macaques against SIV with class II HLAs [4] , the finding that discordance at DRB3 conveyed partial protection from HIV-1 transmission seems reasonable and biologically plausible. Other studies have shown that alloimmunization in humans [20] and allogenic stimulation of CD8 T cell lines [21] produce anti-HIV-1 (suppressor) factors.
All together, these findings suggest that incorporation of HLAs into HIV-1 vaccine design may be useful.
Alloimmunization with HLAs for prophylactic immunization against HIV-1 has been discussed as an approach that may produce sterilizing (complete) immunity independent of HIV-1 mutations [22] . Alloimmunization appears to be safe in other situations. More than 2000 women have been immunized with their partners' leukocytes to prevent recurrent spontaneous abortions, without detectable adverse effects [23] . Moreover, a vaccine design that combines HLA and HIV-1 factors might result in a more specific immune response than that to HLAs alone and potentially minimize adverse effects. The results of this study suggest that further investigation of the roles of class II HLAs in HIV-1 transmission and as possible components of HIV-1 vaccines should be pursued.
